WOKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30

WORK Medical Technology Group LTD

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 30, 2026

$1.20+0.11 (+10.09%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

WORK Medical Technology Group LTD income statement

AnnualQuarterlyTTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30
Revenue	9.85	12	14	20
Gross Profit	2.34	2.87	4.14	4.42
Research & Development	0.44	0.30	0.30	0.18
General & Administrative	2.33	4.56	1.86	2.56
Operating Expenses	4.84	6.91	3.73	3.78
Interest Expense	0.50	0.56	0.39	0.35
Interest & Investment Income	0.18	0.01	0.03	0.00
Other Non-Operating Income	1.41	0.38	-0.30	0.48
Gain (Loss) on Sale of Assets	-0.18	-0.04	-0.01	0.01
Pretax Income	-1.08	-3.67	0.11	1.11
Income Tax Expense	0.12	-0.13	0.05	0.17
Net Income incl. Noncontrolling Interests	-1.20	-3.54	0.06	0.94
Minority Interest in Earnings	-0.13	-0.05	-0.05	0.08
Net Income	-1.07	-3.49	0.11	0.87
EPS (Basic)(per share)	-38,911.84	-262,654.92	9,727.96	68,095.72
EPS (Diluted)(per share)	-38,911.84	-262,654.92	9,727.96	68,095.72
Shares Outstanding (Basic, Weighted)(shares)	0.00	0.00	0.00	0.00
Shares Outstanding (Diluted, Weighted)(shares)	0.00	0.00	0.00	0.00

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY2025

Gross margin: 23.8%
Operating margin: –
Net margin: -10.9%
Return on equity, FY2025: -6.8%

Financial strength

Current ratio: 1.37
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 20.6%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –